Fressart V - Search Results

1

Mexiletine differentially restores the trafficking defects caused by two brugada syndrome mutations.

Moreau A, Keller DI, Huang H, Fressart V, Schmied C, Timour Q, Chahine M. Moreau A, et al. Among authors: fressart v. Front Pharmacol. 2012 Apr 20;3:62. doi: 10.3389/fphar.2012.00062. eCollection 2012. Front Pharmacol. 2012. PMID: 22529811 Free PMC article.

2

A novel mutation in SCN5A, delQKP 1507-1509, causing long QT syndrome: role of Q1507 residue in sodium channel inactivation.

Keller DI, Acharfi S, Delacrétaz E, Benammar N, Rotter M, Pfammatter JP, Fressart V, Guicheney P, Chahine M. Keller DI, et al. Among authors: fressart v. J Mol Cell Cardiol. 2003 Dec;35(12):1513-21. doi: 10.1016/j.yjmcc.2003.08.007. J Mol Cell Cardiol. 2003. PMID: 14654377

3

Brugada syndrome and fever: genetic and molecular characterization of patients carrying SCN5A mutations.

Keller DI, Rougier JS, Kucera JP, Benammar N, Fressart V, Guicheney P, Madle A, Fromer M, Schläpfer J, Abriel H. Keller DI, et al. Among authors: fressart v. Cardiovasc Res. 2005 Aug 15;67(3):510-9. doi: 10.1016/j.cardiores.2005.03.024. Cardiovasc Res. 2005. PMID: 15890323 Free article.

4

The occurrence of Brugada syndrome and isolated cardiac conductive disease in the same family could be due to a single SCN5A mutation or to the accidental association of both diseases.

Six I, Hermida JS, Huang H, Gouas L, Fressart V, Benammar N, Hainque B, Denjoy I, Chahine M, Guicheney P. Six I, et al. Among authors: fressart v. Europace. 2008 Jan;10(1):79-85. doi: 10.1093/europace/eum271. Epub 2007 Dec 21. Europace. 2008. PMID: 18156160

5

De novo heterozygous desmoplakin mutations leading to Naxos-Carvajal disease.

Keller DI, Stepowski D, Balmer C, Simon F, Guenthard J, Bauer F, Itin P, David N, Drouin-Garraud V, Fressart V. Keller DI, et al. Among authors: fressart v. Swiss Med Wkly. 2012 Sep 4;142:w13670. doi: 10.4414/smw.2012.13670. eCollection 2012. Swiss Med Wkly. 2012. PMID: 22949226 Free article.

6

Novel SCN5A mutations in two families with "Brugada-like" ST elevation in the inferior leads and conduction disturbances.

Maury P, Moreau A, Hidden-Lucet F, Leenhardt A, Fressart V, Berthet M, Denjoy I, Bennamar N, Rollin A, Cardin C, Guicheney P, Chahine M. Maury P, et al. Among authors: fressart v. J Interv Card Electrophysiol. 2013 Aug;37(2):131-40. doi: 10.1007/s10840-013-9805-7. Epub 2013 Apr 24. J Interv Card Electrophysiol. 2013. PMID: 23612926

7

Prevalence and significance of rare RYR2 variants in arrhythmogenic right ventricular cardiomyopathy/dysplasia: results of a systematic screening.

Roux-Buisson N, Gandjbakhch E, Donal E, Probst V, Deharo JC, Chevalier P, Klug D, Mansencal N, Delacretaz E, Cosnay P, Scanu P, Extramiana F, Keller D, Hidden-Lucet F, Trapani J, Fouret P, Frank R, Fressart V, Fauré J, Lunardi J, Charron P. Roux-Buisson N, et al. Among authors: fressart v. Heart Rhythm. 2014 Nov;11(11):1999-2009. doi: 10.1016/j.hrthm.2014.07.020. Epub 2014 Jul 17. Heart Rhythm. 2014. PMID: 25041964 Free article.

8

Physiological and Pathophysiological Insights of Nav1.4 and Nav1.5 Comparison.

Loussouarn G, Sternberg D, Nicole S, Marionneau C, Le Bouffant F, Toumaniantz G, Barc J, Malak OA, Fressart V, Péréon Y, Baró I, Charpentier F. Loussouarn G, et al. Among authors: fressart v. Front Pharmacol. 2016 Jan 14;6:314. doi: 10.3389/fphar.2015.00314. eCollection 2015. Front Pharmacol. 2016. PMID: 26834636 Free PMC article. Review.

9

High risk of heart failure associated with desmoglein-2 mutations compared to plakophilin-2 mutations in arrhythmogenic right ventricular cardiomyopathy/dysplasia.

Hermida A, Fressart V, Hidden-Lucet F, Donal E, Probst V, Deharo JC, Chevalier P, Klug D, Mansencal N, Delacretaz E, Cosnay P, Scanu P, Extramiana F, Keller DI, Rouanet S, Charron P, Gandjbakhch E. Hermida A, et al. Among authors: fressart v. Eur J Heart Fail. 2019 Jun;21(6):792-800. doi: 10.1002/ejhf.1423. Epub 2019 Feb 21. Eur J Heart Fail. 2019. PMID: 30790397 Free article.

10

Novel G1481V and Q1491H SCN5A Mutations Linked to Long QT Syndrome Destabilize the Nav1.5 Inactivation State.

Plumereau Q, Theriault O, Pouliot V, Moreau A, Morel E, Fressart V, Denjoy I, Delinière A, Bessière F, Chevalier P, Gamal El-Din TM, Chahine M. Plumereau Q, et al. Among authors: fressart v. CJC Open. 2020 Oct 5;3(3):256-266. doi: 10.1016/j.cjco.2020.09.023. eCollection 2021 Mar. CJC Open. 2020. PMID: 33778442 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

62 results

Search Page

Filters